通过肺部注射对金斯化物Rg1脂质体的药理动力学研究
Ping Liang1, Jie Zhang1, Juan Hou1
1Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei Province, China.
在肺部注射金斯化物Rg1脂质体显著提高了生物可用性. 这种新型的脂质体配方改善了人参化物Rg1 (Rg1) 的持续释放和治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药品制造 药品制造 药品制造
- 药理动力学 药理动力学
背景情况:
- 来自Panax notoginseng的金色化物Rg1 (Rg1) 具有有限的口服生物利用率 (1-20%) 和快速消除.
- 开发Rg1的持续释放,高生物可用性配方对于其治疗应用至关重要.
研究的目的:
- 在大鼠中通过肺部 route 给药的金氏化物Rg1脂质体的药理动力学参数的评估.
- 评估脂质体配方在改善Rg1生物可用性和持续释放方面的潜力.
主要方法:
- 用薄膜分散超声波方法制备了金色化物Rg1脂质体.
- 用肺 perfusion 技术在老鼠身上进行了药理动力学分析.
- 确定了脂质体的特征 (形状,大小,封装效率).
主要成果:
- 金色化物Rg1脂质体呈现圆形,均的形状,颗粒大小为2-3微米,封装效率为51.2%.
- 与Rg1溶液相比,Rg1脂质体的肺部注射导致检测时间更长.
- 肺部用Rg1脂质体的相对生物利用率显著增加 (AUC_脂质体/AUC_溶液=122.67%).
结论:
- 在肺部注射金斯化物Rg1脂质体提供了一个有前途的策略,以提高生物可用性和实现持续释放.
- 这项研究为开发先进的Rg1剂型和注射途径提供了基础.
更多相关视频
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
07:48Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
Published on: January 7, 2019
相关概念视频
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Factors Influencing Drug Absorption: Presystemic Elimination
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
